The 16S rRNA sequencing results of the intestinal contents from the colitis mouse model treated with Mosla chinensis extracts (PRJCA052221)
Mice with colitis were administered the optimal doses of Elsholtzia essential oil or aqueous extract by oral gavage. During the intervention period, body weight, colon length, and histopathological features based on H&E-stained colon sections were recorded. In addition, 16S rRNA sequencing of intestinal contents was performed, along with serum biochemical analyses and protein expression assays. By integrating these data, the therapeutic effects of Mosla chinensis extracts on colitis and their potential underlying mechanisms were systematically evaluated.